Skip to main content
Clinical Trials/ACTRN12618001615279
ACTRN12618001615279
Completed
未知

Clinician Intervention to Reduce Fear of Recurrence in Cancer Survivors (CIFeR Study)

Psycho-Oncology Cooperative Group0 sites61 target enrollmentOctober 2, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
breast cancer
Sponsor
Psycho-Oncology Cooperative Group
Enrollment
61
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 2, 2018
End Date
April 28, 2020
Last Updated
5 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Psycho-Oncology Cooperative Group

Eligibility Criteria

Inclusion Criteria

  • 1\)Women aged 18 years and above with histologically confirmed early stage (I\-III inclusive) breast cancer who have undergone treatment with curative intent
  • 2\)Completed surgery and adjuvant chemotherapy/radiotherapy (where appropriate) greater than or equal to 6 months from time of registration (but may be on adjuvant hormone therapy)
  • 3\)Willing and able to complete study requirements including patient\-rated outcome (PRO) surveys without assistance or translation
  • 4\)Completed signed written informed consent

Exclusion Criteria

  • 1\)Current severe major depression (as defined by \>15 on DASS\-21\) and anxiety (\>21 on DASS\-21\)
  • 2\)Current psychotic illness or other psychiatric/cognitive condition that would impair the ability to participate in the intervention (as judged by the treating clinician)
  • 3\)Patients who are unable to understand written or spoken English
  • 4\)Objective evidence of recurrence or metastatic cancer of any type, as determined by the treating oncologist.

Outcomes

Primary Outcomes

Not specified

Similar Trials